Eli Lilly and Co LLY:NYSE

RT Quote | Last NYSE, VOL From CTA | USD

Last | 1:29 PM EDT

753.81

-6.19 (-0.81%)

Volume

874,177

52 week range

419.80 - 800.78

Open763.50
Day High763.55
Day Low750.53
Prev Close760.00
52 Week High800.78
52 Week High Date03/04/24
52 Week Low419.80
52 Week Low Date05/25/23

Key Stats

Market Cap716.425B
Shares Out950.41M
10 Day Average Volume3.37M
Dividend5.20
Dividend Yield0.69%
Beta0.35
YTD % Change29.59

KEY STATS

Open763.50
Day High763.55
Day Low750.53
Prev Close760.00
52 Week High800.78
52 Week High Date03/04/24
52 Week Low419.80
52 Week Low Date05/25/23
Market Cap716.425B
Shares Out950.41M
10 Day Average Volume3.37M
Dividend5.20
Dividend Yield0.69%
Beta0.35
YTD % Change29.59

RATIOS/PROFITABILITY

EPS (TTM)6.79
P/E (TTM)110.96
Fwd P/E (NTM)55.20
EBITDA (TTM)12.912B
ROE (TTM)51.15%
Revenue (TTM)35.932B
Gross Margin (TTM)80.16%
Net Margin (TTM)17.08%
Debt To Equity (MRQ)204.58%

EVENTS

Earnings Date08/08/2024(est)
Ex Div Date05/15/2024
Div Amount1.30
Split Date-
Split Factor-

Latest On Eli Lilly and Co

Google's Demis Hassabis is the man tasked with turning AI research into profits5 Hours AgoCNBC.com
Healthy Returns: Eli Lilly, Novo Nordisk are boosting weight loss drug supply May 7, 2024CNBC.com
New rivals could threaten Novo Nordisk, Eli Lilly's weight loss drug dominance May 7, 2024CNBC.com
What's driving this multiday rally, plus Jim Cramer's quick takes on 4 stocksMay 6, 2024CNBC.com
Generative AI will be designing new drugs all on its own in the near futureMay 5, 2024CNBC.com

Content From Our Affiliates

Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), TruBridge (TBRG) and Ligand Pharma (LGND)10 Hours AgoTipRanks
Cipla Wants to Partner with Eli Lilly (NYSE:LLY) in IndiaMay 10, 2024TipRanks
Rani Therapeutics price target raised to $14 from $7 at BTIGMay 9, 2024TipRanks
Wall Street Analysts Are Bullish on Top Healthcare PicksMay 9, 2024TipRanks
Drugmakers work to make treatments to maintain weight loss, WSJ reportsMay 8, 2024TipRanks

Profile

Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz....

David Ricks

Chairman of the Board, President, Chief Executive Officer

Anat Ashkenazi

Chief Financial Officer, Executive Vice President

Diogo Rau

Executive Vice President, Chief Information and Digital Officer

Patrik Jonsson

Executive Vice President, President of Lilly Diabetes and Obesity and President of Lilly USA

Alonzo Weems

Executive Vice President - Enterprise Risk Management, Chief Ethics and Compliance Officer

Address

Lilly Corporate Ctr

Drop Code 1094, Lilly Corporate Ctr

Indianapolis, IN

46285-0001

United States

https://www.lilly.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	128.30	-1.76	-1.35%
ABBV AbbVie Inc	161.03	+0.28	+0.18%
JNJ Johnson & Johnson	150.44	+0.53	+0.35%
AZN AstraZeneca PLC	77.28	+0.10	+0.14%
NVS Novartis AG	102.30	+0.20	+0.20%